Clinical Trials Logo

Filter by:
NCT ID: NCT02074540 Not yet recruiting - Diabetes Type II Clinical Trials

The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance

Start date: April 2014
Phase: N/A
Study type: Observational

To determine the predicting factors and indicators of compliance with insulin treatment in Diabetes Type II patients.

NCT ID: NCT02078505 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Gut Microbiome in Patients With Polycystic Ovary Syndrome

Start date: April 2014
Phase: N/A
Study type: Interventional

The polycystic ovary syndrome is intimately associated with body weight and nutrition.The genomic era did not bring a breakthrough to the understanding of the syndrome. The recent surge of studies on gut microbiome has raised the possibility that the specific diet, which often affect these women favorably, would change their gut microbiome. Hence, the investigators will examine their gut microbial population in comparison to normal ovulatory women and then examine whether a low carbohydrate diet causes favorable change in their gut microbial population.

NCT ID: NCT02083575 Not yet recruiting - Thalassemia Major Clinical Trials

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Start date: April 2014
Phase: Phase 2/Phase 3
Study type: Interventional

role of Vit C to Augment iron chelation with DFP or DFX in thalassemic patients.

NCT ID: NCT02084355 Not yet recruiting - Pain Clinical Trials

Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain

Start date: April 2014
Phase: Phase 3
Study type: Interventional

Although opioid rotation is well known treatment modality in reducing pain and opioid-induced neurotoxicity, it is not established whether opioid rotation is more appropriate or opioid escalation is more effective in controlling significant pain in cancer patients under opioid medication. - The purpose of this study is to determine effective therapy out of opioid rotation and opioid dose escalation in patients with moderate to severe cancer pain who have been already treated with strong opioid.

NCT ID: NCT02084927 Not yet recruiting - Neurologic Deficits Clinical Trials

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Start date: April 2014
Phase: Phase 1
Study type: Interventional

The aim of the current study is to evaluate, in a prospective cross-over, randomized study, the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological deficits and cognitive impairment after anterior skull base meningioma tumor removal.

NCT ID: NCT02087332 Not yet recruiting - Clinical trials for Chronic Heart Failure

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

Start date: April 2014
Phase: Phase 4
Study type: Interventional

Study hypothesis is that the time from randomization to the increase of natriuresis (%), time to standardization of natriuresis daily profile, blood pressure profile and the percentage reduction of central hemodynamic parameters will be relatively changed over the study period by more than 15%.

NCT ID: NCT02087410 Not yet recruiting - Polycystic Ovary Clinical Trials

Serum Ghrelin in Polycystic Ovary Syndrome

Start date: April 2014
Phase: N/A
Study type: Observational

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

NCT ID: NCT02088983 Not yet recruiting - Clinical trials for First Episode Schizophrenia

Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia

Start date: April 2014
Phase: Phase 2
Study type: Interventional

People with schizophrenia tend to have problems with attention and concentration. Studies found that these patients are unable to block or gate out non-relevant and distracting information (e.g., noises). This may lead to brain overload. Cognitive abilities like concentration, memory, and learning may worsen. This ability to filter sensory information has been linked to a gene that affects the way nicotine acts in the brain. Patients with schizophrenia have a high rate of cigarette smoking. 60% to 90% smoke compared with 25% of the general population. It has been suggested that these patients may use nicotine to improve their ability to block out distracting information. Brain wave activity (EEG) in response to sounds has been proved useful in understanding this gating problem. The present study uses EEG measures and performance tasks to find out what a new nicotine-like treatment, which will be added to ongoing treatment medications, does to gating and cognition. It is hoped that this new treatment will improve the way in which patients process information, as this may help them in day-to-day activities.

NCT ID: NCT02089490 Not yet recruiting - Clinical trials for Reconstructive Surgery

Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery

NEVAL
Start date: April 2014
Phase: N/A
Study type: Interventional

The dermal substitute NEVELIA® has received CE marking in July 9, 2013. Its use in the NEVAL protocol will be in accordance with its leaflet, i.e. for the treatment of burns or in case of reconstructive plastic surgery. The matric implantation will be followed by autologous skin grafting when the neodermis formation will be observed.

NCT ID: NCT02090166 Not yet recruiting - Lung Cancer Clinical Trials

Lung Cancer Detection by Measuring Monocyte Activity

EDLC
Start date: April 2014
Phase: N/A
Study type: Interventional

Purpose: To evaluate the performance of Extracellular Monitoring of Metabolic Activity Profiles of Peripheral Blood Mononuclear Cells (PBMC) analysis method in identifying lung cancer. The study population will include a total of 950 participants, patients with lung cancer before any treatment, and healthy and COPD patients as a control group.